Observations on the metabolism of morphine to hydromorphone in pain patients

Journal of Analytical Toxicology

Volumn 36, Issue 4, 2012, Pages 250-256

  Hughes, Michelle M ^a   Atayee, Rabia S ^a,b   Best, Brookie M ^a,e   Pesce, Amadeo J ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c Millennium Research Institute   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; MORPHINE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; MAJOR CLINICAL STUDY; PAIN; CHRONIC PAIN; DOSE RESPONSE; FACTUAL DATABASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; RETROSPECTIVE STUDY; TIME;

ANALGESICS, OPIOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC PAIN; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROMORPHONE; MASS SPECTROMETRY; MORPHINE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84864545452     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks021     Document Type: Article

References (18)

1. Governale, L. (2010) July 22-23, Joint meeting of the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee: Outpatient prescription opioid utilization in the U.S., years 2000-2009. United States Food and Drug Administration. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/ucm220948.htm (accessed September 2011).
2. Drug Abuse Warning Network. (2010) 2009 National estimates of drug-related emergency department visits, 2004-2009. Center for Behavioral Health Statistics and Quality, SAMHSA. http://dawninfo.samhsa.gov/data/default.asp?met=All (accessed September 2011).
3. Heit, H.A., Gourlay, D.L. (2004) Urine drug testing in pain medicine. Journal of Pain and Symptom Management, 27, 260-267.
4. Pesce, A., Rosenthal, M., West, R., West, C., Crews, B., Mikel, C. et al. (2010) An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician, 13, 273-281.
5. Mikel, C., Almazan, P., West, R., Crews, B., Pesce, A., West, C. (2009) LC-MS/MS extends the range of drug analysis in pain patients. Therapeutic Drug Monitoring, 31, 746-748.
6. Lugo, R.A., Kern, S.E. (2002) Clinical pharmacokinetics of morphine. Journal of Pain and Palliative Care Pharmacotherapy, 16, 5-18.
7. Cone, E.J., Heit, H.A., Caplan, Y.H., Gourlay, D. (2006) Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. Journal of Analytical Toxicology, 30, 1-5.
8. Hailes, A.M., Bruce, N.C. (1993) Biological synthesis of the analgesic hydromorphone, an intermediate in the metabolism of morphine, by Pseudomonas putida M10. Applied and Environmental Microbiology, 59, 2166-2170.
9. Morbidity and Mortality Weekly Report (MMWR). (2010) Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. JAMA, 303, 21-28.
10. Cook, J.D., Caplan, Y.H., LoDico, C.P., Bush, D.M. (2000) The characterization of human urine for specimen validity determination in workplace drug testing: A review. Journal of Analytical Toxicology, 24, 579-588.
11. West, R., Crews, B., Mikel, C., Almazan, P., Latyshev, S., Pesce, A. et al. (2009) Anomalous observations of codeine in patients on morphine. Therapeutic Drug Monitoring, 31, 776-778.
12. Cone, E.J., Caplan, Y.H., Moser, F., Robert, T., Shelby, M.K., Black, D.L. (2009) Normalization of urinary drug concentrations with specific gravity and creatinine. Journal of Analytical Toxicology, 33, 1-7.
13. Bland, J., Altman, D. (1996) Transformations, means, and confidence intervals. BMJ, 312, 1079.
14. MedlinePlus. (2007) Creatinine-urine. http://www.nlm.nih.gov/medlineplus/ency/article/003610.htm (accessed March 20, 2012).
15. Cone, E.J., Caplan, Y.H., Moser, F., Robert, T., Black, D. (2008) Evidence that morphine is metabolized to hydromorphone but not to oxymorphone. Journal of Analytical Toxicology, 32, 319-323.
16. Reisfield, G.M., Chronister, C.W., Goldberger, B.A., Bertholf, R.L. (2009) Unexpected urine drug testing results in a hospice patient on high-dose morphine therapy. Clinical Chemistry, 55, 1765-1768.
17. McDonough, P.C., Levine, B., Vorce, S., Jufer, R.A., Fowler, D. (2008) The detection of hydromorphone in urine specimens with high morphine concentrations. Journal of Forensic Sciences, 53, 752-754.
18. Wasan, A.D., Michna, E., Janfaza, D., Greenfield, S., Teter, C.J., Jamison, R.N. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine. Pain Medicine, 9, 918-923 (2008).